Literature DB >> 28616318

Is tumor location an independent prognostic factor in locally advanced non-small cell lung cancer treated with trimodality therapy?

Kazuhiko Shien1, Shinichi Toyooka1,2, Junichi Soh1, Hiromasa Yamamoto1, Shinichiro Miyoshi1.   

Abstract

Entities:  

Year:  2017        PMID： 28616318      PMCID： PMC5465126          DOI： 10.21037/jtd.2017.03.183

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  14 in total

1.  Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy.

Authors:  Kazuhiko Shien; Shinichi Toyooka; Junichi Soh; Katsuyuki Hotta; Kuniaki Katsui; Takahiro Oto; Susumu Kanazawa; Katsuyuki Kiura; Hiroshi Date; Shinichiro Miyoshi
Journal:  Mol Clin Oncol       Date:  2015-02-11

2.  Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station.

Authors:  Y Ichinose; H Kato; T Koike; R Tsuchiya; T Fujisawa; N Shimizu; Y Watanabe; T Mitsudomi; M Yoshimura; M Tsuboi
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

3.  Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis.

Authors:  Shinichi Toyooka; Katsuyuki Kiura; Mitsuhiro Takemoto; Takahiro Oto; Nagio Takigawa; Toshiyoshi Fujiwara; Shinichiro Miyoshi; Hiroshi Date
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-20

4.  Clinical Predictors of Persistent Mediastinal Nodal Disease After Induction Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer.

Authors:  Mohamed K Kamel; Mohamed Rahouma; Galal Ghaly; Abu Nasar; Jeffrey L Port; Brendon M Stiles; Andrew B Nguyen; Nasser K Altorki; Paul C Lee
Journal:  Ann Thorac Surg       Date:  2016-09-09       Impact factor: 4.330

5.  Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.

Authors:  S-H Ignatius Ou; Jason A Zell; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

6.  Role of surgery in N2 NSCLC: pros.

Authors:  Kazuhiko Shien; Shinichi Toyooka
Journal:  Jpn J Clin Oncol       Date:  2016-09-21       Impact factor: 3.019

7.  Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Nithya Ramnath; Thomas J Dilling; Loren J Harris; Anthony W Kim; Gaetane C Michaud; Alex A Balekian; Rebecca Diekemper; Frank C Detterbeck; Douglas A Arenberg
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 8.  The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement.

Authors:  Renato G Martins; Thomas A D'Amico; Billy W Loo; Mary Pinder-Schenck; Hossein Borghaei; Jamie E Chaft; Apar Kishor P Ganti; Feng-Ming Spring Kong; Mark G Kris; Inga T Lennes; Douglas E Wood
Journal:  J Natl Compr Canc Netw       Date:  2012-05       Impact factor: 11.908

9.  Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.

Authors:  D C Betticher; S-F Hsu Schmitz; M Tötsch; E Hansen; C Joss; C von Briel; R A Schmid; M Pless; J Habicht; A D Roth; A Spiliopoulos; R Stahel; W Weder; R Stupp; F Egli; M Furrer; H Honegger; M Wernli; T Cerny; H-B Ris
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

10.  Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer.

Authors:  H Katayama; H Ueoka; K Kiura; M Tabata; T Kozuki; M Tanimoto; T Fujiwara; N Tanaka; H Date; M Aoe; N Shimizu; M Takemoto; Y Hiraki
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640
View more
  1 in total

1.  Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.

Authors:  Ahmed Hosny; Chintan Parmar; Thibaud P Coroller; Patrick Grossmann; Roman Zeleznik; Avnish Kumar; Johan Bussink; Robert J Gillies; Raymond H Mak; Hugo J W L Aerts
Journal:  PLoS Med       Date:  2018-11-30       Impact factor: 11.069
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.